CJL
NVO

Cyrus J. Lawrence’s Novo Nordisk NVO Stock Holding History

Cyrus J. Lawrence’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-240
Closed -$20K – 123
2024
Q4 		$20K Sell
240
-38,212
-99% -$4.13M ﹤0.01% 153
2024
Q3 		$4.58M Sell
38,452
-25,566
-40% -$3.41M 0.9% 36
2024
Q2 		$9.14M Buy
64,018
+687
+1% +$91K 1.85% 21
2024
Q1 		$8.13M Buy
+63,331
New +$7.54M 1.8% 25
2023
Q3 		$5.6M Buy
+61,612
New +$5.43M 1.54% 34

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cyrus J. Lawrence's NVO Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 240 shares — an estimated $20K sold.

Cyrus J. Lawrence first reported a position in NVO in Q3 2023 and held it in 5 quarters. The position peaked at $9.14M in Q2 2024. 1,531 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Cyrus J. Lawrence reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Cyrus J. Lawrence sold 240 Novo Nordisk shares in Q1 2025, an estimated $20K.
  • Cyrus J. Lawrence first reported a position in Novo Nordisk in Q3 2023 and held it in 5 quarters.
  • Cyrus J. Lawrence's Novo Nordisk position peaked at $9.14M in Q2 2024.
  • 1,531 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.